NCT05609253 2025-08-08
Itraconazole to Prevent Recurrent Barrett's Esophagus
University of Kansas Medical Center
Phase 1 Active not recruiting
Clinical Trials
12 trialsNCT03852576 2022-11-22
Phase 1B Study of KSP/QRH Dimer for Detection of Neoplasia in the Esophagus
University of Michigan
Phase 1 Terminated
NCT03589443 2019-08-05
Study of Multiplexed Heptapeptides for Detection of Neoplasia in the Esophagus
University of Michigan
Phase 1 Completed
NCT01630798 2015-10-08
NTR 1B
University of Michigan
Phase 1 Completed
NCT01238042 2014-12-02
Study To Determine The Maximum Range of Light Doses At Two HPPH Doses With Acceptable Normal Tissue Toxicity For PDT Treatment Of High Grade Dysplasia,CIS or Early Adenocarcinoma In Barrett's Esophagus
Roswell Park Cancer Institute
Phase 1 Completed
NCT00233935 2014-09-11
Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's Esophagus
National Cancer Institute (NCI)
Phase 1 Completed
NCT01905202 2014-08-04
The Safety and Tolerability of Secretrol in Patients With Barrett's Esophagus
Effexus Pharmaceutical
Phase 1 Unknown
NCT01236443 2014-01-13
Study of Photodynamic Therapy (PDT) Using HPPH in Barrett's Esophagus
Roswell Park Cancer Institute
Phase 1 Completed
NCT01984580 2013-11-14
Effect of Zinc on Barrett's Metaplasia
Main Line Health
Phase 1 Unknown
NCT00566800 2013-09-17
Erlotinib in Treating Patients With Barrett Esophagus
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00573911 2013-01-17
Acid Reflux and Stromal Fibroblasts in Barrett's Esophagus
Mayo Clinic
Phase 1 Completed
NCT00216788 2010-03-16
The Effect of Nexium on Transmucosal Esophageal Leak
Main Line Health
Phase 1 Unknown